Rosansky Steven J, Eggers Paul, Jackson Kirby, Glassock Richard, Clark William F
Dorn Research Institute, Wm. Jennings Bryan Dorn Veterans Hospital, 526 N Trenholm Rd, Columbia, SC 29206, USA.
Arch Intern Med. 2011 Mar 14;171(5):396-403. doi: 10.1001/archinternmed.2010.415. Epub 2010 Nov 8.
A dramatic increase in the "early start" of dialysis with an estimated glomerular filtration rate (eGFR) at least 10 mL/min/1.73 m(2) has occurred in the United States since at least 1996. Several recent studies have reported a comorbidity-adjusted survival disadvantage of early start of dialysis. The current study examines a relatively "healthy" dialysis cohort to minimize confounding issues and determine whether early initiation of hemodialysis is associated with a survival benefit or harm.
We examined demographics, year of dialysis initiation, primary etiology of renal failure, and body mass index, hemoglobin, and serum albumin levels in 81,176 nondiabetic, 20- to 64-year-old, in-center incident hemodialysis patients with no reported comorbidity besides hypertension. We compared survival, using a piecewise proportional hazards model to estimate covariate-adjusted mortality hazard ratios (HRs) for eGFR at the time of initiation of dialysis. We also performed time-dependent adjusted analysis stratified by initial serum albumin levels lower than 2.5 g/dL, 2.5 to 3.49 g/dL, and 3.5 g/dL or higher (the "healthiest" group [HG]).
Unadjusted 1-year mortality by eGFR ranged from 6.8% in the reference group (eGFR <5.0 mL/min/1.73 m(2)) to 20.1% in the highest eGFR group (≥15.0 mL/min/1.73 m(2)). Compared with the reference group, the HR for the HG was 1.27 (eGFR, 5.0-9.9 mL/min/1.73 m(2)), 1.53 (eGFR, 10.0-14.9 mL/min/1.73 m(2)), and 2.18 (eGFR ≥15.0 mL/min/1.73 m(2)) and ranged from 1.50 to 3.53 mL/min/1.73 m(2) in the first year of dialysis for the early-start group.
The increased HR during hemodialysis associated with early start in the healthiest group of patients undergoing dialysis indicates that early start of dialysis may be harmful.
自1996年以来,美国估算肾小球滤过率(eGFR)至少为10 mL/min/1.73 m²时的“早期开始”透析情况急剧增加。最近的几项研究报告了早期开始透析在合并症调整后的生存劣势。本研究考察了一个相对“健康”的透析队列,以尽量减少混杂问题,并确定早期开始血液透析是否与生存获益或危害相关。
我们考察了81176名非糖尿病、20至64岁、中心内新发病例血液透析患者的人口统计学特征、透析开始年份、肾衰竭的主要病因、体重指数、血红蛋白和血清白蛋白水平,这些患者除高血压外无其他合并症报告。我们比较了生存率,使用分段比例风险模型来估计透析开始时eGFR的协变量调整死亡率风险比(HRs)。我们还按初始血清白蛋白水平低于2.5 g/dL、2.5至3.49 g/dL和3.5 g/dL或更高(“最健康”组[HG])进行了时间依赖性调整分析。
按eGFR未调整的1年死亡率在参考组(eGFR<5.0 mL/min/1.73 m²)中为6.8%,在最高eGFR组(≥15.0 mL/min/1.73 m²)中为20.1%。与参考组相比,HG的HR在透析第一年早期开始组中,eGFR为5.0 - 9.9 mL/min/1.73 m²时为1.27,eGFR为10.0 - 14.9 mL/min/1.73 m²时为1.53,eGFR≥15.0 mL/min/1.73 m²时为2.18,范围为1.50至3.53 mL/min/1.73 m²。
在接受透析的最健康患者组中,早期开始透析与血液透析期间HR增加相关,这表明早期开始透析可能有害。